Published in J Virol on January 01, 1979
Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus. J Virol (1999) 1.89
Ultrastructural-immunohistochemical evidence for a maturation defect of temperature-sensitive G31 vesicular stomatitis virus in murine spinal cord neurons. Infect Immun (1979) 0.92
Murine central nervous system infection by a viral temperature-sensitive mutant: a subacute disease leading to demyelination. Am J Pathol (1981) 0.88
Neuroblastoma cell fusion by a temperature-sensitive mutant of vesicular stomatitis virus. J Virol (1979) 0.85
Detection of vesicular stomatitis virus (VSV) RNA in the central nervous system of infected mice by in situ hybridization. Acta Neuropathol (1988) 0.83
Neurovirulence mutant of vesicular stomatitis virus with an altered target cell tropism in vivo. Infect Immun (1980) 0.81
The relationship between glycosylation and glycoprotein metabolism of mouse neuroblastoma N18 cells. Biochem J (1980) 0.78
Vesicular stomatitis virus-infected cells fuse when the intracellular pool of functional M protein is reduced in the presence of G protein. J Virol (1985) 0.76
Neuropeptide-induced hypothermia and the course of central nervous system disease mediated by temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1985) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Genetic characteristics of conditional lethal mutants of vesicular stomatitis virus induced by 5-fluorouracil, 5-azacytidine, and ethyl methane sulfonate. J Virol (1970) 5.43
Improved method for staining cell monolayers for virus plaque counts. J Bacteriol (1959) 4.94
Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. J Virol (1977) 4.03
Envelope proteins of vesicular stomatitis virus: effect of temperature-sensitive mutations in complementation groups III and V. J Virol (1974) 3.73
Maturation of viral proteins in cells infected with temperature-sensitive mutants of vesicular stomatitis virus. J Virol (1977) 3.30
Analysis of the defects of temperature-sensitive mutants of vesicular stomatitis virus: intracellular degradation of specific viral proteins. J Virol (1977) 2.52
Temperature-sensitive mutants of vesicular stomatitis virus: synthesis of virus-specific proteins. J Virol (1971) 2.05
Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 2.05
Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular stomatitis virus. Infect Immun (1974) 1.62
Association of vesicular stomatitis virus proteins with HeLa cell membranes and released virus. J Virol (1976) 1.57
Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Infect Immun (1976) 1.53
Inhibition of RNA synthesis in mouse myeloma cells infected with vesicular stomatitis virus. J Virol (1978) 1.51
The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus. J Gen Virol (1977) 1.03
Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus. Br J Exp Pathol (1976) 1.02
Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (1994) 18.08
Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science (1986) 11.74
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol (1985) 5.73
Primary demyelination in Theiler's virus infection. An ultrastructural study. Lab Invest (1975) 3.45
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med (1995) 2.62
Theiler's virus-induced demyelination: prevention by immunosuppression. Science (1976) 2.59
Ribonucleic acid and protein synthesis in mitotic HeLa cells. J Cell Biol (1965) 1.98
Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity (1995) 1.97
Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology (1990) 1.90
Molecular cloning and partial sequencing of hepatitis A viral cDNA. J Virol (1985) 1.82
Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am J Pathol (1982) 1.81
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol Cell Neurosci (1995) 1.78
Neutralizing monoclonal antibodies to hepatitis A virus: partial localization of a neutralizing antigenic site. J Virol (1984) 1.78
Multiple sclerosis. Animal model:Theiler's virus infection in mice. Am J Pathol (1977) 1.73
High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus. Hum Gene Ther (1998) 1.68
Astrocytes, not microglia, are the main cells responsible for viral persistence in Theiler's murine encephalomyelitis virus infection leading to demyelination. J Neuroimmunol (2001) 1.62
Theiler's virus antigen detected in mouse spinal cord 2 1/2 years after infection. Neurology (1984) 1.62
Humoral immunity to adeno-associated virus type 2 vectors following administration to murine and nonhuman primate muscle. J Virol (2000) 1.57
Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer. Science (1999) 1.57
Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur J Immunol (1993) 1.53
Striking similarity of murine nectin-1alpha to human nectin-1alpha (HveC) in sequence and activity as a glycoprotein D receptor for alphaherpesvirus entry. J Virol (2000) 1.53
Comparison of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Infect Immun (1976) 1.53
Chronic neurologic disease in Theiler's virus infection of SJL/J mice. J Neurol Sci (1976) 1.52
Susceptibility of inbred mice to chronic central nervous system infection by Theiler's murine encephalomyelitis virus. Infect Immun (1979) 1.50
An NADP/thioredoxin system in leaves: purification and characterization of NADP-thioredoxin reductase and thioredoxin h from spinach. Arch Biochem Biophys (1988) 1.48
Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein. J Neuroimmunol (1992) 1.41
A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol (2000) 1.40
The 5' noncoding sequences from a less virulent Theiler's virus dramatically attenuate GDVII neurovirulence. J Virol (1991) 1.37
Murine model for study of cell-mediated immunity: protection against death from fully virulent Francisella tularensis infection. Infect Immun (1975) 1.37
Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. J Immunol (1990) 1.34
The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci U S A (1996) 1.34
Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors. Mol Ther (2000) 1.32
Experimental models of virus-induced demyelination of the central nervous system. Ann Neurol (1982) 1.31
A virus-induced molecular mimicry model of multiple sclerosis. J Clin Invest (2001) 1.31
Transcription from the gene encoding the herpesvirus entry receptor nectin-1 (HveC) in nervous tissue of adult mouse. Virology (2001) 1.25
Cellular immunity in chronic Theiler's virus central nervous system infection. J Immunol (1976) 1.24
The TO strains of Theiler's viruses cause "slow virus-like" infections in mice. Ann Neurol (1979) 1.23
Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. J Clin Invest (1999) 1.22
Salmonella meningitis. A report of three cases and review of the literature. Am J Dis Child (1972) 1.22
Vaginal douching in teenagers attending a family planning clinic. J Adolesc Health Care (1989) 1.17
A phase I study of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator gene to a lung segment of individuals with cystic fibrosis. Hum Gene Ther (1999) 1.16
Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis. Cell Immunol (2000) 1.16
Contrasting modes of photosynthetic enzyme regulation in oxygenic and anoxygenic prokaryotes. Arch Microbiol (1984) 1.14
Schwann cell remyelination and recurrent demyelination in the central nervous system of mice infected with attenuated Theiler's virus. Am J Pathol (1980) 1.12
Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease. J Immunol (1995) 1.11
Recurrent demyelination in chronic central nervous system infection produced by Theiler's murine encephalomyelitis virus. J Neurol Sci (1979) 1.10
Inhibition of Theiler's virus-mediated demyelination by peripheral immune tolerance induction. J Immunol (1995) 1.09
The rate of treatment of chronic hepatitis C in patients co-infected with HIV in an urban medical centre. J Viral Hepat (2005) 1.08
Synthesis and turnover of plasma-membrane proteins and glycoproteins in a neuroblastoma cell line. Biochem J (1976) 1.08
Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice. J Immunol (1988) 1.06
Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease. III. Failure of neuroantigen-specific immune tolerance to affect the clinical course of demyelination. J Neuroimmunol (1990) 1.06
Role of E4 in eliciting CD4 T-cell and B-cell responses to adenovirus vectors delivered to murine and nonhuman primate lungs. J Virol (1998) 1.06
Cyclic loading of transosseous rotator cuff repairs: tension overload as a possible cause of failure. Arthroscopy (1997) 1.06
Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. I. Passive transfer of protection with immune serum and immune cells. J Immunol (1973) 1.05
The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells. J Virol (1995) 1.05
Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. J Immunol (1990) 1.04
Central nervous system demyelination in Venezuelan equine encephalomyelitis infection. J Neurol Sci (1981) 1.04
The uncoupled relationship between the temperature-sensitivity and neurovirulence in mice of mutants of vesicular stomatitis virus. J Gen Virol (1977) 1.03
The efficacy of image-guided stereotactic brain biopsy in neurologically symptomatic acquired immunodeficiency syndrome patients. Neurosurgery (1992) 1.03
An ultrastructural study of central nervous system disease produced by wild-type and temperature-sensitive mutants of vesicular stomatitis virus. Lab Invest (1976) 1.03
Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J Clin Invest (2000) 1.02
Host defenses during primary Venezuelan equine encephalomyelitis virus infection in mice. II. In vitro methods for the measurement and qualitation of the immune response. J Immunol (1973) 1.02
Status spongiousus resulting from intracerebral infection of mice with temperature-sensitive mutants of vesicular stomatitis virus. Br J Exp Pathol (1976) 1.02
Mutation of a major histocompatibility class I locus, H-2D, leads to an increased virus burden and disease susceptibility in Theiler's virus-induced demyelinating disease. J Neurovirol (1995) 1.01
Measurement and comparison of the proliferative and antibody response of neonatal, immature and adult murine spleen cells to T-dependent and T-independent antigens. Cell Immunol (1976) 1.01
Intact B-cell activity is essential for complete expression of experimental allergic encephalomyelitis in Lewis rats. Cell Immunol (1982) 1.01
Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol (1990) 1.00
An inactivated hepatitis A viral vaccine of cell culture origin. J Med Virol (1986) 0.99
Treatment of established relapsing experimental autoimmune encephalomyelitis with the proteasome inhibitor PS-519. J Autoimmun (2000) 0.98
Progressive multifocal leukoencephalopathy in patients with HIV infection: lack of impact of early diagnosis by stereotactic brain biopsy. J Acquir Immune Defic Syndr (1992) 0.98
Repeated administration of adenoviral vectors in lungs of human CD4 transgenic mice treated with a nondepleting CD4 antibody. J Immunol (1999) 0.98
The effects of phenylalanine on amino acid metabolism and protein synthesis in brain cells in vitro. J Neurochem (1976) 0.98
Alteration in the level of interferon-gamma results in acceleration of Theiler's virus-induced demyelinating disease. J Neuroimmunol (1994) 0.97
Presence of Cu/Zn superoxide dismutase (SOD) immunoreactivity in neuronal hyaline inclusions in spinal cords from mice carrying a transgene for Gly93Ala mutant human Cu/Zn SOD. Acta Neuropathol (1998) 0.97
Keto/enol epoxy steroids as HIV-1 Tat inhibitors: structure-activity relationships and pharmacophore localization. J Med Chem (1995) 0.97
Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev (2006) 0.96
Spinal manipulation for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev (2001) 0.95
Thioredoxin system of the photosynthetic anaerobe Chromatium vinosum. J Bacteriol (1984) 0.95
Regulation of protein synthesis in developing mouse brain tissue. Alteration in ribosomal activity. J Biol Chem (1970) 0.95
Post-infectious encephalomyelitis after successful treatment of herpes simplex encephalitis with adenine arabinoside: ultrastructural observations. N Engl J Med (1979) 0.95
The mechanism of polyribosome disaggregation in brain tissue by phenylalanine. Biochem J (1975) 0.94
Adoptively transferred CD8+ T lymphocytes provide protection against TMEV-induced demyelinating disease in BALB/c mice. J Immunol (1996) 0.93
BALB/c substrain differences in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Neuroimmunol (1994) 0.93
Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE. J Neuroimmunol (1997) 0.92
Ultrastructural-immunohistochemical evidence for a maturation defect of temperature-sensitive G31 vesicular stomatitis virus in murine spinal cord neurons. Infect Immun (1979) 0.92